Cargando…
Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer
SIMPLE SUMMARY: Acquired resistance to molecularly targeted therapies remains a major challenge in the treatment of cancer. It has been hypothesized that drug-tolerant (or “persister”) cells without bona fide resistance mechanisms may survive initial drug treatment and undergo further evolution over...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198243/ https://www.ncbi.nlm.nih.gov/pubmed/34071428 http://dx.doi.org/10.3390/cancers13112666 |